EA200702212A1 - Способ лечения или профилактики разрушения кости или остеопороза - Google Patents

Способ лечения или профилактики разрушения кости или остеопороза

Info

Publication number
EA200702212A1
EA200702212A1 EA200702212A EA200702212A EA200702212A1 EA 200702212 A1 EA200702212 A1 EA 200702212A1 EA 200702212 A EA200702212 A EA 200702212A EA 200702212 A EA200702212 A EA 200702212A EA 200702212 A1 EA200702212 A1 EA 200702212A1
Authority
EA
Eurasian Patent Office
Prior art keywords
osteoporosis
prevention
bone destruction
treatment
risk
Prior art date
Application number
EA200702212A
Other languages
English (en)
Other versions
EA012246B1 (ru
Inventor
Роберт И. Дадли
Original Assignee
Юнимед Фармасьютикалз, Инк.
Лаборатуар Безен Энтернасьональ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юнимед Фармасьютикалз, Инк., Лаборатуар Безен Энтернасьональ filed Critical Юнимед Фармасьютикалз, Инк.
Publication of EA200702212A1 publication Critical patent/EA200702212A1/ru
Publication of EA012246B1 publication Critical patent/EA012246B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

Настоящее изобретение имеет отношение к наружному водно-спиртовому лекарственному препарату в виде геля, содержащему тестостерон, и к способу лечения, профилактики или снижения риска развития разрушения кости. Настоящее изобретение также имеет отношение к способу лечения, профилактики или снижения риска развития остеопороза.
EA200702212A 2005-04-12 2006-04-11 Способ лечения или профилактики разрушения кости или остеопороза EA012246B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67058005P 2005-04-12 2005-04-12
PCT/US2006/013551 WO2006110777A1 (en) 2005-04-12 2006-04-11 Method of treating or preventing bone deterioration or osteoporosis

Publications (2)

Publication Number Publication Date
EA200702212A1 true EA200702212A1 (ru) 2008-04-28
EA012246B1 EA012246B1 (ru) 2009-08-28

Family

ID=37087357

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200702212A EA012246B1 (ru) 2005-04-12 2006-04-11 Способ лечения или профилактики разрушения кости или остеопороза

Country Status (11)

Country Link
US (1) US20080058299A1 (ru)
EP (1) EP1868437A4 (ru)
JP (1) JP2008538753A (ru)
CN (1) CN101217874B (ru)
AU (1) AU2006235453A1 (ru)
BR (1) BRPI0609074A2 (ru)
CA (1) CA2604400A1 (ru)
EA (1) EA012246B1 (ru)
IL (1) IL186369A0 (ru)
NO (1) NO20075801L (ru)
WO (1) WO2006110777A1 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US8883769B2 (en) * 2003-06-18 2014-11-11 White Mountain Pharma, Inc. Methods for the treatment of fibromyalgia and chronic fatigue syndrome
US20040259852A1 (en) * 2003-06-18 2004-12-23 White Hillary D. Trandsdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
CN101287470B (zh) 2005-10-12 2012-10-17 优尼麦德药物股份有限公司 改良的睾酮凝胶及使用方法
WO2009142699A1 (en) * 2008-05-19 2009-11-26 The Procter & Gamble Company Treatment of heart failure in women
US10080760B2 (en) 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
US9850425B2 (en) 2010-08-11 2017-12-26 Conocophillips Company Delayed gelling agents
WO2012068410A1 (en) 2010-11-18 2012-05-24 White Mountain Pharma, Inc. Methods for treating chronic or unresolvable pain and/or increasing the pain threshold in a subject and pharmaceutical compositions for use therein
US9950125B2 (en) 2012-04-06 2018-04-24 Antares Pharma, Inc. Needle assisted jet injection administration of testosterone compositions
AU2013374213B2 (en) 2013-01-18 2016-09-22 Conocophillips Company Nanogels for delayed gelation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
US5760096A (en) * 1996-10-18 1998-06-02 Thornfeldt; Carl R. Potent penetration enhancers
KR20030048021A (ko) * 2000-08-30 2003-06-18 유니메드 파마슈티칼스, 인크. 여성의 테스토스테론 및 관련된 스테로이드의 농도를증가시키는 방법
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
JP5039252B2 (ja) * 2000-08-31 2012-10-03 ユニメッド ファーマシューティカルズ，リミティド ライアビリティ カンパニー 性機能低下を治療するための医薬組成物及び方法

Also Published As

Publication number Publication date
JP2008538753A (ja) 2008-11-06
IL186369A0 (en) 2008-01-20
AU2006235453A1 (en) 2006-10-19
NO20075801L (no) 2008-01-07
EA012246B1 (ru) 2009-08-28
CA2604400A1 (en) 2006-10-19
CN101217874A (zh) 2008-07-09
EP1868437A4 (en) 2009-08-05
BRPI0609074A2 (pt) 2010-02-17
EP1868437A1 (en) 2007-12-26
US20080058299A1 (en) 2008-03-06
CN101217874B (zh) 2012-06-06
AU2006235453A2 (en) 2006-10-19
WO2006110777B1 (en) 2006-11-30
WO2006110777A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
EA200702212A1 (ru) Способ лечения или профилактики разрушения кости или остеопороза
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
ATE395871T1 (de) Marknagel zur behandlung von proximalen oberschenkelknochenbrüchen
EA200600078A1 (ru) Способы и композиции для лечения амилоидных заболеваний
ATE448744T1 (de) Vorrichtung zur behandlung von frakturen des femur
ATE457166T1 (de) Orale zusammensetzungen zur behandlung von diabetes
ATE376444T1 (de) Ibandronsäure zur behandlung und vorbeugung von osteoporose
DE60328476D1 (de) Medizinisches ballonsystem zur behandlung von adipositas
DE502005010499D1 (de) Implantat zur Behandlung von Fettsucht
ATE414089T1 (de) Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust
EA200801164A3 (ru) Ингибиторы протеина, активирующего 5-липоксигеназу (flap)
DE602004010407D1 (de) Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden
EA201000584A1 (ru) Ингибиторы протеина, активирующего 5-липоксигеназу (flap)
DE602007011908D1 (de) Verwendung von gpr119-rezeptoragonisten zur vermehrung der knochenmasse und zur behandlung von osteoporose sowie kombinationstherapie dafür
ATE354563T1 (de) Sulfonderivate zur hemmung von gamma-secretase
TW200510334A (en) Preraration and use of aryl alkyl acid derivatives for the treatment of obesity
WO2003074550A3 (en) Pin1-modulating compounds and methods of use thereof
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
ATE435026T1 (de) Verfahren zur prävention und behandlung von diabetes mit neurturin
WO2005007123A3 (en) Pin1-modulating compounds and methods of use thereof
NO20080037L (no) Kombinasjon av pyrimidylaminobenzamidforbindelser og imatinib for behandling eller forbyggelse av proliferative sykdommer
ATE410235T1 (de) Behandlung von ballastwasser
DE60223707D1 (de) Calcium-l-threonat zur behandlung von knochenfrakturen
DE602005007471D1 (de) Satraplatin zur behandlung von resistenten oder refrkatären tumoren
DE602006010364D1 (de) Pharmazeutikum zur prävention oder behandlung von metabolischer knochenkrankheit

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title